Abstract
Fisetin (FIS) is a flavonoid aglycone which is widely distributed in several fruits and vegetables. Based on its complex biochemical action in the body, FIS seems a promising candidate for the treatment of neurodegenerative diseases, diabetes, or cancer. During the 3′-O-methylation of FIS by catechol-O-methyltransferase geraldol (GER) is formed which is also pharmacologically active. Similarly to other flavonoids, FIS and GER are poorly soluble in water. Microcapsulation of flavonoids can enhance their aqueous solubility and may improve their pharmacokinetic properties. Since both FIS and GER are fluorescent molecules, the interaction of these flavonoids by native and chemically modified β-cyclodextrins was investigated by fluorescence spectroscopy. Both FIS-CD and GER-CD complexes show considerable emission with maxima at 475 and 540nm reflecting the two conformers of the complexes. Thereafter, fluorescence enhancement of each tautomer by cyclodextrins and binding constants of flavonoid-cyclodextrin complexes were determined. Chemically modified cyclodextrins were stronger fluorescence enhancers of flavonoids and formed more stable complexes with FIS and GER than the native β-cyclodextrin. Finally, influence of cyclodextrins on the cellular impact of FIS and GER was tested on HepG2 tumor cell line.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
